Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

Keck School of Medicine of USC
S

The Past, the Present, and the Future of TNBC: Recent Updates and Most Important Trials

By Keck School of Medicine of USC FEATURING Sara Tolaney
February 13, 2022
1 Comment
Login to view comments. Click here to Login

Featured Video

17:04
Novartis Oncology

Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…

Feat. G. Hortobagyi

Featured Video

22:25
Novartis Oncology

The Importance of Dosing and Patient Adherence in HR+/HER2- mBC

Feat. N. McAndrew
9th Annual USC Multi-Disciplinary Breast Cancer Symposium
30:46
Keck School of Medicine of USC

2022 Updates on the Adjuvant Treatment of Early Stage HER2+ BC

Feat. J. O'Shaughnessy
33:55
Keck School of Medicine of USC

Improving Outcomes for Patients With HR+ BC: From Metastatic to Earl…

Feat. H. Rugo
37:19
Keck School of Medicine of USC

The Past, the Present, and the Future of TNBC: Recent Updates and Mo…

Feat. S. Tolaney
32:59
Keck School of Medicine of USC

I SPY 2.2: Responsive, Adaptive Trial to Prioritize Promising Invest…

Feat. L. Esserman